VYCOR MEDICAL INC
Close on Oct 19, 2026
- Market cap
- $2.24M
- P/E (TTM)
- –
- Dividend yield
- –
About Vycor Medical
Surgical & Medical Instruments & Apparatus, SIC 3841
Vycor Medical, Inc. operates within the medical device industry across two distinct divisions: Vycor Medical and NovaVision. The Vycor Medical division designs, develops, and commercializes medical devices tailored for neurosurgery, featuring its ViewSite Brain Access System for surgical access and retraction during brain and spine procedures. NovaVision supplies computer-based, non-invasive rehabilitation therapies designed for patients suffering from visual impairments caused by neurological brain trauma, such as strokes, utilizing products like Vision Restoration Therapy and NeuroEyeCoach.
The company maintains corporate headquarters in Boca Raton, Florida, where it leases office facilities. Its medical devices and rehabilitation products hold regulatory clearances and registrations across several international markets, including the United States, Europe, and Canada. Vycor Medical employs a workforce of seven personnel and markets its surgical solutions and therapeutic platforms internationally through direct channels, distribution networks, and strategic commercial partnerships.
Summary of the business section of Vycor Medical's latest annual report, written by StockData.
Company profile
Company
- Legal name
- VYCOR MEDICAL INC
- Founded
- 2005
- Headquarters
- Boca Raton,, FL
- Address
- 951 Broken Sound Parkway, Suite 320 33487
- Phone
- (562) 558-2000
- Website
- vycormedical.com
- Employees
- 7, Dec 31, 2025
- Industry
- Surgical & Medical Instruments & Apparatus
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- Prager Metis CPAs, LLC, Hackensack, New Jersey
Stock & identifiers
- Ticker
- VYCO
- Exchange
- OTC
- Shares outstanding
- 33M, Aug 14, 2026
- Public float
- $1.71M, Jun 30, 2025
- Filer category
- Non-accelerated filer<br>Smaller reporting company
- Stock splits
- 1-for-150 reverse, Apr 1, 2013
- SEC CIK
- 1424768
- EIN
- 20-3369218
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
No recent ownership filings by officers or directors
Vycor Medical's leadership is listed in its proxy statement (Form DEF 14A).
Employees
Headcount reported in annual reports
“We currently have 7 employees.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Mar 31, 2025 | Late filing | Notification of late filing |
| Apr 1, 2024 | Late filing | Notification of late filing |
| Mar 31, 2023 | Late filing | Notification of late filing |
| Apr 1, 2022 | Late filing | Notification of late filing |
| Aug 17, 2020 | Late filing | Notification of late filing |
| Oct 12, 2018 | Auditor change | Change in certifying accountant (8-K Item 4.01) |
| Apr 28, 2016 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Mar 31, 2014 | Late filing | Notification of late filing |
| Nov 14, 2013 | Late filing | Notification of late filing |
| Aug 15, 2011 | Late filing | Notification of late filing |
| Feb 14, 2011 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Dec 3, 2010 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Oct 27, 2010 | Listing | Registration of securities on an exchange (Form 8-A) |
| Nov 16, 2009 | Late filing | Notification of late filing |
| Mar 31, 2009 | Late filing | Notification of late filing |